Genetic Technologies (GENE) Spikes, Signs Licensing Agreement with Conexio Genomics
Tweet Send to a Friend
Up)
In compliance with ASX Continuous Disclosure Rules, Genetic Technologies Limited (Nasdaq: GENE) is pleased to report it has now executed a License Agreement with Conexio Genomics Pty. Ltd. (“Conexio”) of Fremantle, Western Australia.
Under the terms of the Agreement, Conexio is granted non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology. As with other similar agreements, the precise commercial terms of the Agreement are covered by formal confidentiality provisions and cannot be disclosed.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Under the terms of the Agreement, Conexio is granted non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology. As with other similar agreements, the precise commercial terms of the Agreement are covered by formal confidentiality provisions and cannot be disclosed.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Traders Jump on Gene Plays (ROSG) (GENE) on Angelina Jolie Mastectomy News
- UPDATE: Google (GOOG) Improves Maps for Mobile
- SolarCity (SCTY), Goldman Sachs (GS) Announce $500M U.S. Rooftop Solar Lease Financing Platform
Create E-mail Alert Related Categories
Corporate News, Momentum Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
